Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.
CONCLUSIONS: The HIV example provides helpful parallels for addressing challenges to expanding access to HCV DAAs. HCV treatment access - and harm reduction - should be massively scaled-up to meet the needs of PWID, and efforts should be made to tackle stigma and discrimination, and stop criminalization of drug use and possession.
PMID: 29633580 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Epidemics | Epidemiology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | HIV AIDS | India Health | Infectious Diseases | Liver | Liver Cancer | Men | Urology & Nephrology